Skip to main content

Table 2 Clinical outcome and complications of PSE in three groups

From: Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes

 

Group 1 (n = 65)

Group 2 (n = 58)

Group 3 (n = 56)

p value

Pain severity score (VAS), (Mean ± SD)

3.2 ± 2.2

3.9 ± 1.1

4.5 ± 2.8

0.004*

Complications

    

Pain

53 (81.5)

49 (84.5)

50 (87.5)

0.491

Fever

59 (90.7)

50 (86.2)

48 (85.7)

0.639

Vomiting

29 (44.6)

22 (37.9)

22 (39.3)

0.725

Ascites

12 (18.5)

7 (12.1)

8 (14.3)

0.601

Pleural effusion

9 (13.8)

7 (12.1)

6 (10.7)

0.870

Splenic abscess

3 (4.6)

1(1.7)

1 (1.8)

0.535

Bacterial peritonitis

2 (3.1)

0 (0)

0 (0)

0.847

Hematemesis

3 (4.6)

1 (1.7)

1 (1.8)

0.535

Portal vein thrombosis

2 (3.1)

1 (1.7)

2 (3.6)

0.823

Procedure related mortality

0 (0)

0 (0)

0 (0)

-

  1. Unless otherwise indicated, data represent the number of patients and percentage in parenthesis
  2. Group 1—Gelfoam group, Group 2—Embosphere microspheres group, Group 3—polyvinyl alcohol
  3. PSE partial splenic embolization, SD standard deviation, VAS visual analogue scale
  4. *Significant